IN190388B - - Google Patents

Info

Publication number
IN190388B
IN190388B IN2930DE1998A IN190388B IN 190388 B IN190388 B IN 190388B IN 2930DE1998 A IN2930DE1998 A IN 2930DE1998A IN 190388 B IN190388 B IN 190388B
Authority
IN
India
Prior art keywords
active compound
biologically active
vesicles
mlcvs
multilamellar
Prior art date
Application number
Other languages
English (en)
Inventor
Lawrence Boni
Michael Batenjany
Stella Gevantmakher
Original Assignee
Biomira Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Usa Inc filed Critical Biomira Usa Inc
Publication of IN190388B publication Critical patent/IN190388B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906Drug delivery
    • Y10S977/907Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN2930DE1998 1997-10-01 1998-01-01 IN190388B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6060697P 1997-10-01 1997-10-01

Publications (1)

Publication Number Publication Date
IN190388B true IN190388B (enExample) 2003-07-26

Family

ID=22030591

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2930DE1998 IN190388B (enExample) 1997-10-01 1998-01-01

Country Status (9)

Country Link
US (1) US6544549B1 (enExample)
EP (1) EP1019026B1 (enExample)
JP (1) JP2001517693A (enExample)
AT (1) ATE286717T1 (enExample)
AU (1) AU745000B2 (enExample)
CA (1) CA2305533C (enExample)
DE (1) DE69828624T2 (enExample)
IN (1) IN190388B (enExample)
WO (1) WO1999016426A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006095798A1 (ja) * 2005-03-09 2006-09-14 Sunstar Inc. フィトステロールを含んだリポソームを含有する抗癌用経口組成物、該リポソームによる癌の予防又は治療
US7662405B2 (en) * 2005-08-09 2010-02-16 The Research Foundation Of State University Of New York Compositions and methods of preparation of liposomal microparticulate IL-12
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
US8597678B2 (en) 2005-12-30 2013-12-03 Dermazone Solutions, Inc. Nanolipidic particles
WO2010059253A2 (en) 2008-11-24 2010-05-27 Massachusets Institute Of Technology Methods and compositions for localized agent delivery
US20100324124A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Compositions and methods relating to DNA-based particles
US20100323018A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Branched DNA/RNA monomers and uses thereof
EP2547327B1 (en) * 2010-03-19 2018-09-05 Massachusetts Institute of Technology Lipid vesicle compositions and methods of use
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
CN102654505A (zh) * 2012-05-16 2012-09-05 江苏省原子医学研究所 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法
DK2925297T3 (en) * 2012-11-02 2017-10-02 Cytuvax COMPOSITION COMPREHENSIVE CYTOCHINE MACROAGGERATES
US9770415B2 (en) * 2012-11-27 2017-09-26 Southwest Research Institute Delivery substrates from aligned polymer biomaterials for tissue repair
EP3049114B1 (en) 2013-09-27 2021-11-10 Massachusetts Institute of Technology Carrier-free biologically-active protein nanostructures
PT3291797T (pt) 2015-05-04 2020-10-19 Versantis AG Método para preparar vesículas de gradiente de ph transmembranar
US11034752B2 (en) 2015-08-12 2021-06-15 Massachusetts Institute Of Technology Cell surface coupling of nanoparticles
CA3029813A1 (en) 2016-06-13 2017-12-21 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
WO2019050978A1 (en) 2017-09-05 2019-03-14 Torque Therapeutics, Inc. THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
US11020355B2 (en) 2018-09-06 2021-06-01 NuVessl, Inc. Method of encapsulating cannabinoids in phospholipid carriers
US20200188301A1 (en) 2018-12-14 2020-06-18 NuVessl, Inc. Method for Enhancing Passenger Molecule Loading
WO2021158996A1 (en) * 2020-02-05 2021-08-12 University Of Florida Research Foundation, Incorporated Rna-loaded nanoparticles and use thereof for the treatment of cancer
US20240285791A1 (en) * 2020-09-04 2024-08-29 Daegu Gyeongbuk Institute Of Science And Technology Extracellular vesicle expressing cytokine and antibody, method for producing same, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04356421A (ja) * 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
ATE306937T1 (de) * 1996-02-16 2005-11-15 Biomira Usa Inc Impfstoff gegen tumore der b-lymphozyten

Also Published As

Publication number Publication date
DE69828624D1 (de) 2005-02-17
EP1019026A2 (en) 2000-07-19
ATE286717T1 (de) 2005-01-15
AU9680098A (en) 1999-04-23
CA2305533A1 (en) 1999-04-08
JP2001517693A (ja) 2001-10-09
DE69828624T2 (de) 2005-12-22
WO1999016426A2 (en) 1999-04-08
EP1019026B1 (en) 2005-01-12
CA2305533C (en) 2009-12-01
AU745000B2 (en) 2002-03-07
US6544549B1 (en) 2003-04-08
WO1999016426A3 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
IN190388B (enExample)
ATE341310T1 (de) Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
WO2000045791A3 (en) Method for controlling liposome size
ES8607906A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
AU8141891A (en) Unilamellar vesicles
HUP9802578A3 (en) Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
DE69614385D1 (de) Verfahren zur herstellung einer liposomen-zubereitung
CA2108288A1 (en) Liposomal cyclosporin formulation and process for the preparation thereof
CA2138925A1 (en) Method of producing reconstituted lipoproteins
CA2227761A1 (en) Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
WO2003000227A3 (en) A method for preparation of vesicles loaded with biological material and different uses thereof
GR3017118T3 (en) Liposomal-polyene preliposomal powder and method for its preparation.
JP2001517693A5 (enExample)
KR880001284A (ko) 단일 이중층 리포좀의 제조방법
CA2079685A1 (en) Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
MY131524A (en) Liposomal itraconazole formulations
HUT62457A (en) Process for producing aqueous liposomal suspensions comprising an active ingredient
CA2202103A1 (en) Method for preparing closed vesicles
IE45651L (en) Pyrrolobenzoxazaalkane derivatives
AU4827497A (en) Concentrated single phase aqueous solutions of tetrahydroiso-alpha-acids and methods of preparing the same
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
WO1999049716A3 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen mit hochdruckhomogemisation
DE3851842D1 (de) Wässrige bereitung von liposomenzusammensetzungen.
ES2110980T3 (es) Composiciones liposomicas y procedimientos para su produccion.